Patents by Inventor Masaru Matsumoto
Masaru Matsumoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20080193997Abstract: An effective liquid preparation achieves high bioavailability (BA) of physiologically active peptides or proteins, including ghrelins, that are administered as drugs. Also provided is a method for improving the BA of physiologically active peptides or proteins, including ghrelins, that are subcutaneously injected in aqueous solutions. The liquid preparation contains: a physiologically active peptide or protein, such as ghrelins, as an active ingredient; an acid solution including one or a combination of two or more selected form the group consisting of acetic acid, lactic acid, phosphoric acid, glycine, citric acid, hydrochloric acid, propionic acid, butyric acid, benzoic acid and salts thereof; an alcohol; and a polar organic liquid including one or a combination of two or more selected from the group consisting of N-methyl-2-pyrrolidone, dimethylformamide, dimethylsulfoxide and methylparaben.Type: ApplicationFiled: August 24, 2005Publication date: August 14, 2008Applicants: Kenji Kangawa, Asubio Pharma Co., Ltd.Inventors: Masaru Matsumoto, Masako Matsumoto, Takeshi Hanada, Naomi Wakabayashi
-
Publication number: 20080081787Abstract: It is provided a pharmaceutical composition stably containing ghrelin or its derivative, which is an endogenous growth hormone secretagogue (GHS) to a growth hormone secretagogue-receptor (GHS-R), comprising a aqueous solution containing the ghrelins having pH range of 2 to 7, wherein the aqueous solution having pH range of 2 to 7 is a buffer solution, especially, glycine hydrochloride buffer, acetate buffer, citrate buffer, lactate buffer, phosphate buffer, citric acid-phosphate buffer, phosphate-acetate-borate buffer or phthalate buffer, and the concentration of the ghrelins in the solution is from 0.03 nmol/mL to 6 ?mol/mL.Type: ApplicationFiled: July 25, 2007Publication date: April 3, 2008Applicants: ASUBIO PHARMA CO., LTDInventors: Yoshiharu Minamitake, Masaru Matsumoto
-
Patent number: 7138489Abstract: The present invention is a method for producing a peptide or a protein in which a side chain contains a modified amino acid residue, which comprises chemically producing a peptide fragment containing an amino acid residue having a modified side chain using an weak acid-cleavable resin, producing a peptide fragment containing no amino acid residue having a modified side chain using a genetic recombination method or/and an enzymatic method, and condensing the resulting two kinds of peptide fragments and, according to the present invention, a peptide or a protein containing modification such as acylation, glycosylation and phosphorylation can be obtained effectively and at high quality.Type: GrantFiled: April 10, 2003Date of Patent: November 21, 2006Assignee: Daiichi Asubio Pharma Co., Ltd.Inventors: Yoshiharu Minamitake, Masaru Matsumoto, Tomohiro Makino
-
Publication number: 20060234679Abstract: An information protection system for a mobile terminal device, the information protection system including: an authentication device for performing a person authentication process when an information protection request for the mobile terminal device is issued in order to identify whether any person being subjected to authentication is an owner of the mobile terminal device by using a personal identity information, the mobile terminal device being capable of performing a predetermined information protection process in accordance with a remote operation information; and a management device for generating the remote operation information in order to perform an information protection process for the mobile terminal device and for transmitting the remote operation information to the mobile terminal device when the person authentication process by the authentication process device matches the personal identity information.Type: ApplicationFiled: April 18, 2006Publication date: October 19, 2006Applicant: Sharp Kabushiki KaishaInventors: Masaru Matsumoto, Hiroshi Tanaka
-
Publication number: 20060166871Abstract: It is provided a pharmaceutical composition stably containing ghrelin or its derivative, which is an endogenous growth hormone secretagogue (GHS) to a growth hormone secretagogue-receptor (GHS-R), comprising a aqueous solution containing the ghrelins having pH range of 2 to 7, wherein the aqueous solution having pH range of 2 to 7 is a buffer solution, especially, glycine hydrochloride buffer, acetate buffer, citrate buffer, lactate buffer, phosphate buffer, citric acid-phosphate buffer, phosphate-acetate-borate buffer or phthalate buffer, and the concentration of the ghrelins in the solution is from 0.03 nmol/mL to 61 ?mol/mL.Type: ApplicationFiled: May 21, 2003Publication date: July 27, 2006Applicants: DAIICHI SUNTORY PHARMA., LTD., KENJI KANGAWAInventors: Yoshiharu Minamitake, Masaru Matsumoto
-
Publication number: 20050131208Abstract: The present invention is a method for producing a peptide or a protein in which a side chain contains a modified amino acid residue, which comprises chemically producing a peptide fragment containing an amino acid residue having a modified side chain using an weak acid-cleavable resin, producing a peptide fragment containing no amino acid residue having a modified side chain using a genetic recombination method or/and an enzymatic method, and condensing the resulting two kinds of peptide fragments and, according to the present invention, a peptide or a protein containing modification such as acylation, glycosylation and phosphorylation can be obtained effectively and at high quality.Type: ApplicationFiled: April 10, 2003Publication date: June 16, 2005Inventors: Yoshiharu Minamitake, Masaru Matsumoto, Tomohiro Makino
-
Patent number: 6528500Abstract: Described is an azole derivative represented by the following formula (1): wherein, R1 represents a substituted phenyl group, R2 and R3 each represents a fluorine atom, an alkyl group or the like, and R4 represents an alkyl group, or salt thereof; and a medicament comprising the derivative or salt as an effective ingredient. The compound according to the present invention exhibits excellent antimycotic action and has good aqueous solubility.Type: GrantFiled: September 28, 2000Date of Patent: March 4, 2003Assignee: SSP Co., Ltd.Inventors: Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
-
Patent number: 6362553Abstract: An object of the present invention is to provide a low cost, high performance, thin structure rotary motor for driving medium used in magnetic disk drive unit, optical disk drive unit or the like, in order to improve the productivity of terminating processing and the reliability of the coils. Magnetic materials which are divided to a plurality of blocks or divided corresponding to respective magnetic pole teeth are connected by means of thin portions. The respective magnetic pole teeth are wound continuously with wire without cutting the wire at the positions in which the thin portions are connected. When a stator is assembled, a plurality of blocks or magnetic pole teeth are disposed on a substrate by separating or bending the thin portions.Type: GrantFiled: December 23, 1998Date of Patent: March 26, 2002Assignee: Mitsubishi Denki Kabushiki KaishaInventors: Yuji Nakahara, Kenichi Azuma, Masaru Matsumoto, Youichi Fujita, Satoru Akutsu, Akira Hashimoto, Yasunori Takai, Tadashi Hasegawa, Hiroshi Miyazaki, Junji Kawada
-
Patent number: 6323571Abstract: An object of the present invention is to provide a low cost, high performance, thin structure rotary motor for driving medium used in magnetic disk drive unit, optical disk drive unit or the like, in order to improve the productivity of terminating processing and the reliability of the coils. Magnetic materials which are divided to a plurality of blocks or divided corresponding to respective magnetic pole teeth are connected by means of thin portions. The respective magnetic pole teeth are wound continuously with wire without cutting the wire at the positions in which the thin portions are connected. When a stator is assembled, a plurality of blocks or magnetic pole teeth are disposed on a substrate by separating or bending the thin portions.Type: GrantFiled: July 11, 2000Date of Patent: November 27, 2001Assignee: Mitsubishi Denki Kabushiki KaishaInventors: Yuji Nakahara, Ken-ichi Azuma, Masaru Matsumoto, Youichi Fujita, Satoru Akutsu, Akira Hashimoto, Yasunori Takai, Tadashi Hasegawa, Hiroshi Miyazaki, Junji Kawada
-
Patent number: 6204415Abstract: Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.Type: GrantFiled: April 18, 2000Date of Patent: March 20, 2001Assignee: SSP Co., Ltd.Inventors: Sunao Takeda, Yasushi Kaneko, Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
-
Patent number: 6194592Abstract: Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.Type: GrantFiled: April 18, 2000Date of Patent: February 27, 2001Assignee: SSP Co., Ltd.Inventors: Sunao Takeda, Yasushi Kaneko, Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
-
Patent number: 6184396Abstract: Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.Type: GrantFiled: April 18, 2000Date of Patent: February 6, 2001Assignee: SSP Co., Ltd.Inventors: Sunao Takeda, Yasushi Kaneko, Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
-
Patent number: 6172266Abstract: Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.Type: GrantFiled: December 23, 1999Date of Patent: January 9, 2001Assignee: SSP Co., Ltd.Inventors: Sunao Takeda, Yasushi Kaneko, Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
-
Patent number: 6167610Abstract: Magnetic materials which are divided into a plurality of blocks or divided corresponding to respective magnetic pole teeth are connected by means of thin portions. The respective magnetic pole teeth are wound continuously with wire without cutting the wire at the positions in which the thin portions are connected. When a stator is assembled, a plurality of blocks or magnetic pole teeth are disposed on a substrate by separating or bending the thin portions.Type: GrantFiled: January 3, 1996Date of Patent: January 2, 2001Assignee: Mitsubishi Denki Kabushiki KaishaInventors: Yuji Nakahara, Ken-ichi Azuma, Masaru Matsumoto, Youichi Fujita, Satoru Akutsu, Akira Hashimoto, Yasunori Takai, Tadashi Hasegawa, Hiroshi Miyazaki, Junji Kawada
-
Patent number: 6121711Abstract: An object of the present invention is to provide a low cost, high performance, thin structure rotary motor for driving medium used in magnetic disk drive unit, optical disk drive unit or the like, in order to improve the productivity of terminating processing and the reliability of the coils. Magnetic materials which are divided to a plurality of blocks or divided corresponding to respective magnetic pole teeth are connected by means of thin portions. The respective magnetic pole teeth are wound continuously with wire without cutting the wire at the positions in which the thin portions are connected. When a stator is assembled, a plurality of blocks or magnetic pole teeth are disposed on a substrate by separating or bending the thin portions.Type: GrantFiled: March 24, 1999Date of Patent: September 19, 2000Assignee: Mitsubishi Denki Kabushiki KaishaInventors: Yuji Nakahara, Ken-ichi Azuma, Masaru Matsumoto, Youichi Fujita, Satoru Akutsu, Akira Hashimoto, Yasunori Takai, Tadashi Hasegawa, Hiroshi Miyazaki, Junji Kawada
-
Patent number: 6083968Abstract: Described is a triazole derivative represented by the formula (1): ##STR1## wherein R.sup.1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X.sup.1 and X.sup.2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient.The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.Type: GrantFiled: December 9, 1998Date of Patent: July 4, 2000Assignee: SSP Co., Ltd.Inventors: Sunao Takeda, Yasushi Kaneko, Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
-
Patent number: 6063945Abstract: A compound having formula (2): ##STR1## wherein R represents hydrogen, a straight or branched C.sub.1-10 alkyl group, a C.sub.7-11 aralkyl group or a C.sub.2-10 carboacyl group and m stands for 1 to 5.Type: GrantFiled: June 8, 1999Date of Patent: May 16, 2000Assignee: SS Pharmaceutical Co., Ltd.Inventors: Minoru Tokizawa, Sunao Takeda, Yasushi Kaneko, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato, Hideaki Matsuda
-
Patent number: 6040325Abstract: Described is a triazole derivative represented by the formula (1): wherein R.sup.1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X.sup.1 and X.sup.2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient.The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.Type: GrantFiled: January 22, 1999Date of Patent: March 21, 2000Assignee: SSP Co., Ltd.Inventors: Sunao Takeda, Yasushi Kaneko, Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
-
Patent number: 6024221Abstract: An ampule storage bag can store ampules for one patient and can engage a transfusion bottle for the same one patient. The ampule storage bag includes a nontransparent sheet and a transparent sheet bonded along the edge to the nontransparent sheet so as to define an opening along the edge. The bag is formed with two holes for engaging a neck of a transfusion bottle. The holes are provided symmetrically with respect to a fold line provided near the opening. Cushion members are provided in the bag to arrange ampules in order in the bag and to prevent breakage of the ampules.Type: GrantFiled: March 23, 1998Date of Patent: February 15, 2000Assignee: Kabushiki Kaisha Yuyama SeisakushoInventors: Shoji Yuyama, Masaru Matsumoto, Hiroshi Nose, Hiroyasu Hamada
-
Patent number: 6025973Abstract: A compact card type disk drive includes a housing (21) for accommodating a disk for storing data, a disk drive for rotating the disk, a head assembly for writing and reading data to and from the disk and an electronic circuit including at least an interface circuit (39), the latter three being accommodated in the housing. A connector (42) connected to the electronic circuit is fixed to the outside portion of the housing (21). The electronic circuit preferably contains a read/write circuit (36) and a control circuit (38). The housing (21) preferably includes a lower base (22) and an upper cover (23), and a printed circuit board (14) is disposed along the inner wall of either one, or both, of the base (22) and the cover (23). The outer dimension of the plane of the disk drive is preferably about 85.6 mm.times.54 mm, and typically, the outer thickness is 5 mm. Preferably, one connector (42) is disposed on either one of the minor sides of the housing (21).Type: GrantFiled: December 17, 1998Date of Patent: February 15, 2000Assignee: Fujitsu LimitedInventors: Yoshifumi Mizoshita, Tomoyoshi Yamada, Yasumasa Kuroba, Toru Kouhei, Takao Sugawara, Masaru Matsumoto, Hiroyuki Mase, Masao Tsunekewa, Shinji Koganezawa, Keiji Aruga